Nikos Papadopoulos is a world leading expert in allergy and asthma, focusing on the role of infection and its interaction with atopy, as keystone events of allergy pathophysiology as well as targets for treatment. In the course of this career, he has identified some of the key mechanisms leading from common viral exposures to asthma exacerbations and allergy persistence. He is Professor and Head of the Allergy Department, 2 nd Pediatric Clinic, University of Athens; also Honorary Professor at the University of Manchester and at OPRI, Singapore. He has supervised more than 30 PhDs, organized over 200 educational events and has trained doctors in the clinic and researchers in the lab. He is an invited speaker at international events more than 30 times a year. He has participated and led several high-impact EU research projects from FP5 all the way to Horizon Europe (2022).
He has actively served many international societies, most notably EAACI (President 2013-2015), the Respiratory Effectiveness Group (REG, President 2018- 2020) and currently Board Member of WAO. He has received several international awards, among other, the EAACI Clemens von Pirquet Award (2019), the PhARF award (2010), the Klosterfrau International Award (2003) and the ERS Annual Award for Pediatric Respiratory Research in Europe (2004). He has published over 600 papers, receiving 50000 citations and an h-index of >100 (Google Scholar).
He has published more than 600 papers, receiving over 70,000 citations and an h-index greater than 119 (Google Scholar). His current research focuses on the role of respiratory viruses in asthma, testing novel interventions for milk and nut allergy, and evaluating potential measures to address indoor air pollution in school environments. He also leads the PeARL Think Tank (Pediatric Asthma in Real Life), which aims to optimize the management of pediatric asthma.
Check his research: https://pubmed.ncbi.nlm.nih.gov/?term=Papadopoulos+NG&sort=date